Patent: 9,937,245
✉ Email this page to a colleague
Summary for Patent: 9,937,245
| Title: | Highly pure neurotoxic component of a botulinum toxin, process for preparing same, and uses thereof |
| Abstract: | The present invention relates to a process for preparing a highly pure neurotoxic component of a toxin by cultivating under conditions that allow production of a toxin, and isolating the neurotoxic component from the toxin. In addition, the present invention relates to a highly pure neurotoxic component of a toxin obtainable by the process of the present invention and uses thereof. |
| Inventor(s): | Pfeil Michael, Wiesenburg Andreas |
| Assignee: | MERZ PHARMA GMBH & CO. KGAA |
| Application Number: | US14908235 |
| Patent Claims: | see list of patent claims |
Details for Patent 9,937,245
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Merz Pharmaceuticals Gmbh C/o Merz Pharmaceuticals Llc | XEOMIN | incobotulinumtoxina | For Injection | 125360 | July 30, 2010 | 9,937,245 | 2034-07-30 |
| Merz Pharmaceuticals Gmbh C/o Merz Pharmaceuticals Llc | XEOMIN | incobotulinumtoxina | For Injection | 125360 | November 20, 2015 | 9,937,245 | 2034-07-30 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 9,937,245
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2015014487 | ⤷ Start Trial |
| United States of America | 2018147266 | ⤷ Start Trial |
| United States of America | 2016175407 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
